The state of Connecticut currently has 13 active clinical trials seeking participants for Ulcerative Colitis research studies. These trials are conducted in various cities, including New Haven, Hartford, Farmington and Stamford.
A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis
Recruiting
This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
09/01/2023
Locations: Yale University, New Haven, Connecticut
Conditions: Ulcerative Colitis